Baños HI, Román GJF, De Armas AI

Language: Spanish
References: 8
Page: 127-130
PDF size: 453.60 Kb.

ABSTRACT

Introduction: Hyperplasia and prostate cancer are very frequent entities from the sixth decade of life. They may cause several urinary disorders but it is unusual that they present as palpable abdominal masses. Objective: To describe how a giant prostatic hyperplasia combined with a small acinar adenocarcinoma appears as an abdominal tumor. Case presentation: Patient attending hospital with a visible tumor Palpable In hypogastrium accompanied by a low urinary obstructive syndrome. Combined, transvesical and retropubic adenomectomy is performed surgically. The biopsy reports small prostatic adenocarcinoma acinar Gleason 3‐4 points in the context of a prostatic hyperplasia. The patient evolved satisfactorily and is followed in consultation. The extracted tumor weighed 736g and is the largest weight reported in Cuba and the fifth in the world. Conclusions: The benign or malignant proliferation of the prostate gland is characterized by anatomical and functional alterations in the urinary system. For this reason causes a varied symptomatology, fundamentally related to the act of micturition. This form of presentation of prostatic tumors is extremely rare but must be taken into account in patients with abdominal masses evident in hypogastrium.

REFERENCES

1. Zhang H, Ma X, Peng S, Nan X, Zhao H. Differential expression of MST4, STK25 and PDCD10 between benign prostatic hyperplasia and prostate cancer. Int J Clin Exp Pathol. 2014 [citado 14 Ene 2015];7(11):[aprox. 8 p.]. Disponible en: http://europepmc.org/abstract/med/25550858

2. Greenstein A, Ferman Z, Stav K, Gruenwald I, Matzkin H, Ramon J. Position statement for the diagnosis and treatment of men with benign prostate enlargement and lower urinary tract symptoms. Harefuah. 2014 [citado 14 Ene 2015];153(9):[aprox. 4 p.]. Disponible en: http://www.pubpdf.com/search/author/Jacob+ Ramon

3. Kumar S, Yadav RN, Gupta P, Gaspar BL, Kakkar N, Verma A, et al. Prostatic hyperplasia in acromegaly, a myth or reality: a case‐control study. Eur J Endocrinol. 2015 [citado 14 Ene 2015];172(2):[aprox. 9 p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/255503 51

4. Fu Y, Zhou Z, Yang B, Zhang K, He L,Zhang X. The Relationship between the Clinical Progression of Benign Prostatic Hyperplasia and Metabolic Syndrome: A Prospective Study. Urol Int. 2016;97(3):330‐335. Epub 2016 Aug 11.

5. Ogawa S, Manome M, Yabe M, Kuma Y, Yamaoka M, Sato Y, et al. A giant prostatic hyperplasia treated by open surgery. Int J Gen Med. 2012;5:1009‐12.

6. Marcelo L, Ariê C, Rodrigo A, Paulo K, Antonio C. Giant prostatic hyperplasia: report of a previously asymptomatic man presenting with gross hematuria and hypovolemic shock. Einstein (São Paulo). 2015;13(3):420‐2.

7. Joseph M, Mousa Emad E, Varna Menon. Giant Prostatic Hyperplasia Fourth largest prostate reported in medical literature. Sultan Qaboos University Med J, May 2014;14(2):e253‐ 256.

8. Furumido J, Abe T, Kikuchi H, Miyajima N, Tsuchiya K, Maruyama S, et al. Giant Prostate Carcinoma: A Case Report and Long‐Term Outcomes in Japanese Patients. Hinyokika Kiyo. 2016;62(7):377‐81.